| Original language | English (US) |
|---|---|
| Pages (from-to) | 565-566 |
| Number of pages | 2 |
| Journal | Headache |
| Volume | 61 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2021 |
Keywords
- committee
- guidelines
- protocol
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Headache, Vol. 61, No. 4, 04.2021, p. 565-566.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Updated process for American Headache Society Guidelines
AU - Hershey, Andrew D.
AU - Armand, Cynthia E.
AU - Berk, Thomas
AU - Burch, Rebecca
AU - Buse, Dawn C.
AU - Dougherty, Carrie
AU - Marmura, Michael J.
AU - Minen, Mia T.
AU - Robblee, Jennifer
AU - Schwarz, Heidi B.
N1 - Funding Information: ADH or his institution has received grant or contract support and/or honorarium for advisory board consultation from AbVie/Allergan, Amgen, Biohaven, Curelator, electroCore, Lilly, Lundbeck, Supernus, Teva, Theranica, and Upsher‐Smith, as well as grant support from the NIH/NINDS and NICHDS, and Migraine Research Foundation. CEA has received honoraria for advisory board consultation from Biohaven and Impel. She is the web editor for . TB has received honoraria for advisory board consultation from Biohaven and Impel. RB receives compensation for her work as an Associate Editor of . DCB has received grant support and honoraria from Allergan, Amgen, Biohaven, Lilly, Novartis, and Promius/Dr. Reddys. She has received grant support from the US Food and Drug Administration and the National Headache Foundation. She serves on the editorial board of . CD has received grants for research (no personal compensation) from electroCore, Eli Lilly, Abvie/Allergan, and Amgen; has received speaking honorarium from Amgen, Biohaven, Eli Lilly, Novartis, Lundbeck, Teva, and serves as a consultant for Allergan, Biohaven, Impel Pharmaceuticals, Lundbeck, Novartis, and Theranica. MJM has received institutional support for serving as principal investigator from Teva, electroCore and AbbVie. He has received honoraria for consultations from Alder/Lundbeck, Antres Pharma, Eli Lilly and Company, Promius, Theranica, and Valeant/Bausch Pharma. He has received compensation for speaker bureau activities from Amgen/Novartis and Eli Lilly and company. MTM serves on the American Academy of Neurology Guidelines Sub‐Committee but this work is not connected to this publication. MTM is also the Co‐Section Head of the Headache Section of . JR has received stipends from MedLink Neurology and IDS/Springer. JR is also the chair of the Refractory Inpatient and Emergency Care Headache Section. HS has consulted for Skipta, Guidepoint, and Dynamed. JAMA Neurology Neurology Current Pain and Headache Reports Pain Medicine Funding Information: The authors are members of the American Headache Society Guidelines Committee.
PY - 2021/4
Y1 - 2021/4
KW - committee
KW - guidelines
KW - protocol
UR - http://www.scopus.com/inward/record.url?scp=85104814232&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104814232&partnerID=8YFLogxK
U2 - 10.1111/head.14093
DO - 10.1111/head.14093
M3 - Editorial
C2 - 33891346
AN - SCOPUS:85104814232
SN - 0017-8748
VL - 61
SP - 565
EP - 566
JO - Headache
JF - Headache
IS - 4
ER -